CL2021000456A1 - Paquetes mensajeros vegetales modificados y usos de los mismos. - Google Patents
Paquetes mensajeros vegetales modificados y usos de los mismos.Info
- Publication number
- CL2021000456A1 CL2021000456A1 CL2021000456A CL2021000456A CL2021000456A1 CL 2021000456 A1 CL2021000456 A1 CL 2021000456A1 CL 2021000456 A CL2021000456 A CL 2021000456A CL 2021000456 A CL2021000456 A CL 2021000456A CL 2021000456 A1 CL2021000456 A1 CL 2021000456A1
- Authority
- CL
- Chile
- Prior art keywords
- uptake
- modified vegetable
- cells
- packages
- messenger
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pest Control & Pesticides (AREA)
- General Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
En el presente documento se divulgan composiciones que incluyen una pluralidad de paquetes mensajeros vegetales (por ejemplo, que incluyen una vesícula vegetal extracelular (VE), o segmento, porción o extracto de la misma), que se han modificado para tener una mayor captación por las células (por ejemplo, captación por células animales, captación por células bacterianas o captación por células fúngicas), por ejemplo, para su uso en una variedad de métodos agrícolas o terapéuticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862722576P | 2018-08-24 | 2018-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021000456A1 true CL2021000456A1 (es) | 2021-07-23 |
Family
ID=69591371
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021000456A CL2021000456A1 (es) | 2018-08-24 | 2021-02-23 | Paquetes mensajeros vegetales modificados y usos de los mismos. |
CL2023001410A CL2023001410A1 (es) | 2018-08-24 | 2023-05-16 | Paquetes mensajeros vegetales modificados y usos de los mismos |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2023001410A CL2023001410A1 (es) | 2018-08-24 | 2023-05-16 | Paquetes mensajeros vegetales modificados y usos de los mismos |
Country Status (17)
Country | Link |
---|---|
US (2) | US20210196632A1 (es) |
EP (1) | EP3840728A4 (es) |
JP (1) | JP2021533794A (es) |
KR (1) | KR20210049138A (es) |
CN (1) | CN112739327A (es) |
AU (1) | AU2019325698A1 (es) |
BR (1) | BR112021003311A2 (es) |
CA (1) | CA3109958A1 (es) |
CL (2) | CL2021000456A1 (es) |
CO (1) | CO2021003128A2 (es) |
EA (1) | EA202190368A1 (es) |
IL (1) | IL280935A (es) |
MA (1) | MA53443A (es) |
MX (1) | MX2021001980A (es) |
PH (1) | PH12021550354A1 (es) |
SG (1) | SG11202101778TA (es) |
WO (1) | WO2020041783A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3099817A1 (en) * | 2018-05-15 | 2019-11-21 | Flagship Pioneering Innovations Vi, Llc | Pathogen control compositions and uses thereof |
CN116849231A (zh) * | 2018-05-15 | 2023-10-10 | 旗舰创业创新六公司 | 有害生物防治组合物及其用途 |
JP2022526678A (ja) * | 2019-04-13 | 2022-05-25 | フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー | ポリペプチドを封入する植物メッセンジャーパック及びその使用 |
MX2021012886A (es) * | 2019-04-25 | 2022-01-04 | Flagship Pioneering Innovations Vi Llc | Composiciones y metodos relacionados con paquetes mensajeros de plantas. |
CA3151814A1 (en) * | 2019-08-24 | 2021-03-04 | Flagship Pioneering Innovations Vi, Llc | Modification of plant messenger packs with charged lipids |
WO2021237215A1 (en) * | 2020-05-22 | 2021-11-25 | University Of Louisville Research Foundation, Inc. | Compositions and methods for preventing and/or treating microbial infections |
CN111748562B (zh) * | 2020-06-15 | 2022-04-29 | 华南农业大学 | 一种水稻纹枯病菌Atg 22蛋白编码基因及其靶标片段Rsatg22和应用 |
CN112646734B (zh) * | 2020-12-31 | 2022-11-29 | 广西壮族自治区林业科学研究院 | 一株兰花菌根真菌pf06及其应用 |
KR20240044415A (ko) * | 2021-06-14 | 2024-04-04 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 식물 메신저 팩의 변형 |
CN114544800B (zh) * | 2022-01-14 | 2023-07-11 | 南通市疾病预防控制中心 | 分子筛串联固相萃取检测甲氧基丙烯酸酯类杀菌剂的方法 |
CN115161215A (zh) * | 2022-03-11 | 2022-10-11 | 中国农业大学 | 一种双歧杆菌的发酵方法及其应用 |
CN114958657B (zh) * | 2022-05-10 | 2023-09-05 | 广东省科学院生物与医学工程研究所 | Chitinophaga eiseniae降解羽毛粉产生生物表面活性剂的应用 |
CN117363664A (zh) * | 2023-08-03 | 2024-01-09 | 长春师范大学 | 一种从牛筋草内生菌Bipolaris sp.提取邻苯二甲酸二丁酯的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920016A (en) * | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
FR2836043B1 (fr) * | 2002-02-15 | 2004-06-04 | Inst Nat Sante Rech Med | Vesicules lipidiques, preparation et utilisations |
US7404969B2 (en) * | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
JP6184945B2 (ja) * | 2011-06-08 | 2017-08-23 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | mRNA送達のための脂質ナノ粒子組成物および方法 |
US20140308212A1 (en) * | 2011-11-07 | 2014-10-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
EA201492055A1 (ru) * | 2012-06-08 | 2015-11-30 | Шир Хьюман Дженетик Терапис, Инк. | ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ |
JP6137894B2 (ja) * | 2013-03-22 | 2017-05-31 | 国立大学法人京都大学 | リポソーム−エキソソームハイブリッドベシクル及びその調製法 |
AU2016288643A1 (en) * | 2015-07-02 | 2018-02-22 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer |
MA46762A (fr) * | 2016-11-10 | 2019-09-18 | Translate Bio Inc | Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm |
WO2018107061A1 (en) * | 2016-12-09 | 2018-06-14 | Board Of Regents, The University Of Texas System | Hybrid exosomal-polymeric (hexpo) nano-platform for delivery of rnai therapeutics |
-
2019
- 2019-08-24 CN CN201980055476.6A patent/CN112739327A/zh active Pending
- 2019-08-24 US US17/270,110 patent/US20210196632A1/en not_active Abandoned
- 2019-08-24 AU AU2019325698A patent/AU2019325698A1/en active Pending
- 2019-08-24 EP EP19851037.2A patent/EP3840728A4/en active Pending
- 2019-08-24 WO PCT/US2019/048046 patent/WO2020041783A1/en unknown
- 2019-08-24 MA MA053443A patent/MA53443A/fr unknown
- 2019-08-24 CA CA3109958A patent/CA3109958A1/en active Pending
- 2019-08-24 SG SG11202101778TA patent/SG11202101778TA/en unknown
- 2019-08-24 EA EA202190368A patent/EA202190368A1/ru unknown
- 2019-08-24 JP JP2021509222A patent/JP2021533794A/ja active Pending
- 2019-08-24 BR BR112021003311-4A patent/BR112021003311A2/pt unknown
- 2019-08-24 KR KR1020217008558A patent/KR20210049138A/ko unknown
- 2019-08-24 MX MX2021001980A patent/MX2021001980A/es unknown
-
2021
- 2021-02-17 IL IL280935A patent/IL280935A/en unknown
- 2021-02-19 PH PH12021550354A patent/PH12021550354A1/en unknown
- 2021-02-23 CL CL2021000456A patent/CL2021000456A1/es unknown
- 2021-03-10 CO CONC2021/0003128A patent/CO2021003128A2/es unknown
- 2021-07-23 US US17/383,821 patent/US20220273565A1/en active Pending
-
2023
- 2023-05-16 CL CL2023001410A patent/CL2023001410A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021533794A (ja) | 2021-12-09 |
PH12021550354A1 (en) | 2021-10-04 |
US20220273565A1 (en) | 2022-09-01 |
WO2020041783A1 (en) | 2020-02-27 |
EA202190368A1 (ru) | 2021-06-10 |
CA3109958A1 (en) | 2020-02-27 |
IL280935A (en) | 2021-04-29 |
BR112021003311A2 (pt) | 2021-05-25 |
CL2023001410A1 (es) | 2023-10-30 |
MX2021001980A (es) | 2021-05-27 |
US20210196632A1 (en) | 2021-07-01 |
AU2019325698A1 (en) | 2021-04-08 |
CO2021003128A2 (es) | 2021-07-30 |
EP3840728A4 (en) | 2022-06-08 |
MA53443A (fr) | 2021-12-01 |
CN112739327A (zh) | 2021-04-30 |
SG11202101778TA (en) | 2021-03-30 |
KR20210049138A (ko) | 2021-05-04 |
EP3840728A1 (en) | 2021-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021003128A2 (es) | Paquetes mensajeros vegetales modificados y usos de los mismos | |
CL2020002946A1 (es) | Composiciones para el control de plagas y uso de las mismas. | |
AR115101A1 (es) | Composiciones para el control de patógenos y usos de las mismas | |
CL2018003343A1 (es) | Uracilpiridinas herbicidas. | |
CO2020005129A2 (es) | Composiciones sinegísticas de pesticidas y métodos para la entrega de ingredientes activos | |
BR112022003021A2 (pt) | Modificação de pacotes mensageiros de plantas com lipídeos carregados | |
CO2021003081A2 (es) | Métodos y composiciones para la modificación de plantas | |
AR109239A1 (es) | Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas | |
UY33634A (es) | ?combinaciones sinérgicas de triazoles, estrobirulinas y benzimidazoles, usos, formulaciones, procedimientos de producción y aplicaciones utilizando las mismas?. | |
CL2020000866A1 (es) | Uso de composiciones que contienen streptomyces melanosporofaciens agl225 en el control de enfermedades de las plantas. | |
CL2018001619A1 (es) | Composiciones basadas en chlorella seca y métodos para el mejoramiento de las plantas. | |
CO2022009748A2 (es) | Tensioactivos para productos agrícolas | |
BR112023026246A2 (pt) | Modificação de pacotes mensageiros de planta | |
UY38318A (es) | Formulaciones de liberación controlada para agroquímicos | |
AR115359A1 (es) | Preparaciones microbianas para plantas, composiciones y formulaciones que las comprenden y sus usos | |
CO2022003732A2 (es) | Métodos para mejorar el tamaño y la calidad de las semillas | |
UY33633A (es) | ?combinación sinérgica de abamectina y bifentrina, su proceso de preparación y uso, y método utilizando la misma" | |
AR096230A1 (es) | Composiciones y métodos para implementar una mezcla de semillas transgénicas de refugio | |
GT201200264A (es) | Composiciones que comprenden material vegetal y azucar para el control de plagas y metodos de fabricacion | |
UY36426A (es) | Métodos para preparar composiciones que contienen alcaloides y usos de las mismas | |
AR111181A1 (es) | Métodos y composiciones para mejorar la salud de la planta y/o el rendimiento de la planta | |
CL2018003354A1 (es) | Composición para modular genes responsables de las funciones generales de la piel, método para modular la expresión de genes responsables de las funciones generales de la piel y uso de un extracto vegetal | |
CO2019000083A2 (es) | Composiciones farmacéuticas | |
AR111561A1 (es) | Método para mejorar la seguridad de los cultivos | |
UY36134A (es) | Mezclas que comprenden una cepa bacillus y un plaguicida |